Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bioavailability of Oniria®, a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers ; volume:22 ; number:3 ; day:2 ; month:8 ; year:2022 ; pages:235-243 ; date:9.2022
Drugs in R & D ; 22, Heft 3 (2.8.2022), 235-243, 9.2022
- Urheber
-
Román Martinez, Manuel
García Aguilar, Eva
Martin Vílchez, Samuel
González García, Javier
Luquero-Bueno, Sergio
Camargo-Mamani, Paola
Mejia-Abril, Gina
García-Castro, Laura
Miguel-Cáceres, Alejandro de
Saz-Leal, Paula
Abad-Santos, Francisco
Nieto Magro, Concepcion
Ochoa Mazarro, Dolores
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-022-00394-3
- URN
-
urn:nbn:de:101:1-2022111821072834746862
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Román Martinez, Manuel
- García Aguilar, Eva
- Martin Vílchez, Samuel
- González García, Javier
- Luquero-Bueno, Sergio
- Camargo-Mamani, Paola
- Mejia-Abril, Gina
- García-Castro, Laura
- Miguel-Cáceres, Alejandro de
- Saz-Leal, Paula
- Abad-Santos, Francisco
- Nieto Magro, Concepcion
- Ochoa Mazarro, Dolores
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
Melatonin Bioavailability After Oral Administration of a New Delayed-Release Form in Healthy Male Volunteers
Melatonin improves memory acquisition under stress independent of stress hormone release
MELATONIN DOSAGE FORMS WITH AN EMPHASIS ON MODIFIED RELEASE DOSAGE FORMS
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Melatonin : 12 Gründe, warum Melatonin die Basis für Ihre Gesundheit ist
Melatonin : das neue Wundermittel
Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
Melatonin Bioavailability After Oral Administration of a New Delayed-Release Form in Healthy Male Volunteers
Melatonin improves memory acquisition under stress independent of stress hormone release
MELATONIN DOSAGE FORMS WITH AN EMPHASIS ON MODIFIED RELEASE DOSAGE FORMS
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Melatonin : 12 Gründe, warum Melatonin die Basis für Ihre Gesundheit ist
Melatonin : das neue Wundermittel
Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers
Melatonin Bioavailability After Oral Administration of a New Delayed-Release Form in Healthy Male Volunteers
Melatonin improves memory acquisition under stress independent of stress hormone release
MELATONIN DOSAGE FORMS WITH AN EMPHASIS ON MODIFIED RELEASE DOSAGE FORMS
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Melatonin : 12 Gründe, warum Melatonin die Basis für Ihre Gesundheit ist